Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS5 | Q9UNA0 | 3/20 | 0.40 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.34 |
| ▸ | MMP14 | P50281 | 1/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29067975 | 0.83 | TSHR (0.43) | ADAMTS5MMP2TSHRADAM17GAA | |
| SCHEMBL1012052 | 0.83 | TSHR (0.43) | ADAMTS5MMP2TSHRADAM17GAA | |
| SCHEMBL29598045 | 0.83 | TSHR (0.43) | ADAMTS5MMP2TSHRADAM17GAA | |
| SCHEMBL30862106 | 0.83 | — | — | |
| SCHEMBL29161773 | 0.80 | ADAMTS5 (0.40) | ADAMTS5MMP2TSHRADAM17GAA | |
| SCHEMBL23462729 | 0.76 | TSHR (0.40) | ADAMTS5MMP2TSHRADAM17GAA | |
| SCHEMBL23391687 | 0.76 | ADAMTS5 (0.38) | ADAMTS5MMP2TSHRADAM17GAA | |
| SCHEMBL20641504 | 0.76 | ADAMTS5 (0.38) | ADAMTS5MMP2TSHRADAM17GAA | |
| SCHEMBL23391680 | 0.76 | ADAMTS5 (0.38) | ADAMTS5MMP2TSHRADAM17GAA | |
| SCHEMBL17884949 | 0.76 | ADAMTS5 (0.49) | ADAMTS5MMP2TSHRADAM17GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119637907-A | Process for producing concentrated carbonate aqueous solution | 住友化学株式会社 | 2025-03-18 | — | — | CN | claimed |
| CN-113166045-B | Method for producing methionine | 赢创运营有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-116102475-A | Methionine composition and preparation method thereof | 万华化学集团股份有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-113166045-A | Method for producing methionine | 赢创运营有限公司 | 2021-07-23 | — | — | CN | claimed |
| CN-110088085-A | Process for the preparation of methionine | 赢创德固赛有限公司 | 2019-08-02 | — | — | CN | claimed |
| CN-109593000-A | The production method of granule containing dipeptides | 赢创德固赛有限公司 | 2019-04-09 | — | — | CN | claimed |
| CN-109415276-A | Particle material containing dipeptides | 赢创德固赛有限公司 | 2019-03-01 | — | — | CN | claimed |
| EP-1975154-B1 | Process for producing Methionine | SUMITOMO CHEMICAL CO (JP) | 2010-06-23 | — | — | EP | claimed |
| EP-1256571-B1 | Process for the preparation of D,L-methionine or a salt thereof | DEGUSSA (DE) | 2006-08-02 | — | — | EP | claimed |
| EP-0839804-B1 | Process for producing methionine | SUMITOMO CHEMICAL CO (JP) | 2002-01-09 | — | — | EP | claimed |
| EP-0253740-B1 | PROCESS FOR THE PREPARATION OF AN AQUEOUS SOLUTION OF THE SODIUM SALT OF METHIONINE | RHONE-POULENC NUTRITION ANIMALE (FR) | 1990-05-30 | — | — | EP | claimed |
| US-4303621-A | Process for the recovery of methionine and potassium bicarbonate | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1981-12-01 | — | — | US | claimed |
| US-12512186-B2 | Method and system for process control | EVONIK OPERATIONS GMBH (DE) | 2025-12-30 | — | — | US | disclosed |
| CN-116102475-B | Methionine composition and preparation method thereof | 万华化学集团股份有限公司 | 2025-08-29 | — | — | CN | disclosed |
| CN-119637907-A | Process for producing concentrated carbonate aqueous solution | 住友化学株式会社 | 2025-03-18 | — | — | CN | disclosed |
| CN-119403784-A | Method for obtaining a mixture containing methionine and potassium bicarbonate | 赢创运营有限公司 | 2025-02-07 | — | — | CN | disclosed |
| US-5770769-A | Process for the preparation of D,L-methionine or the salt thereof | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1998-06-23 | — | — | US | disclosed |
| US-5756803-A | WITHOUT AMINES | RHONE-POULENC NUTRITION ANIMALE (FR) | 1998-05-26 | — | — | US | disclosed |
| EP-0739870-A1 | Process for the condensation of hydrogen cyanide with an aldehyde | RHONE-POULENC NUTRITION ANIMALE (FR) | 1996-10-30 | — | — | EP | disclosed |
| EP-0058771-A1 | Use of aqueous solutions of sodium or potassium methionate for the supplementation of mixed provenders with methionine | Degussa Aktiengesellschaft (DE) | 1982-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12512186-B2 | Method and system for process control | HVCN1, TASP1, BHMT2 | ADAMTS5 1721/4885MMP2 3689/4885TSHR 1678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.